Tuyển tập các báo cáo nghiên cứu về hóa học được đăng trên tạp chí sinh học quốc tế đề tài : A Population-Based and Longitudinal Study of Sexual Behavior and Multidrug-Resistant HIV Among Patients in Clinical Care | Journal of the International AIDS Society BioMed Central Research article A Population-Based and Longitudinal Study of Sexual Behavior and Multidrug-Resistant HIV Among Patients in Clinical Care Michael J Kozal 1 K Rivet Amico2 Jennifer Chiarella3 Deborah Cornman4 William Fisher5 Jeffrey Fisher6 and Gerald Friedland7 Open Access Address 1Associate Professor of Medicine Yale University School of Medicine and Acting Chief of Infectious Diseases VA CT Healthcare System New Haven Connecticut 2Affiliate Center for Health HIV Intervention Prevention University of Connecticut Storrs Connecticut 3Research Assistant AIDS Program Yale University New Haven Connecticut 4Associate Director Center for Health HIV Intervention Prevention University of Connecticut Storrs Connecticut 5Professor Department of Psychology and Department of Obstetrics and Gynecology University of Western Ontario London Ontario Canada 6Professor of Psychology Director Center for Health HIV Intervention Prevention CHIP University of Connecticut Storrs Connecticut and 7Professor of Medicine Epidemiology and Public Health AIDS Program Yale New Haven Hospital Yale School of Medicine New Haven Connecticut Email Michael J Kozal - Corresponding author Published 13 June 2006 Journal of the International AIDS Society 2005 8 72 This article is available from http content 8 2 72 Abstract Background Population-based and longitudinal information regarding sexual risk behavior among patients with multidrug resistant MDR HIV and their sexual partners is of great public health and clinical importance. Objective To characterize the HIV sexual risk behaviors of patients with and without drug-resistant HIV in the clinical care setting over time. Measurements 393 HIV-positive patients completed questionnaires of self-reported sexual risk behaviors at approximate 6-month intervals extending over 24 months. HIV viral load and genotypic drug resistance obtained during the same time .
